Hao-Ran Dai

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Preterm Infants

Small Cell Lung Cancer

Top Venues

Expert opinion on drug metabolism & toxicology

Pharmaceuticals (Basel, Switzerland)

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Hao-Ran Dai, Hong-Li Guo, Ya-Hui Hu, Yun Liu, Ke-Yu Lu, Yuan-Yuan Zhang, Jie Wang, Xuan-Sheng Ding, Zheng Jiao, Rui Cheng, Feng Chen
Development and application of a population pharmacokinetic model repository for caffeine dose tailoring in preterm infants. Expert opinion on drug metabolism & toxicology (2024)
Chen-Yu Wang, Hao-Ran Dai, Yu-Ping Tan, Di-Hong Yang, Xiao-Min Niu, Lu Han, Wen Wang, Ling-Ling Ma, Aleksi Julku, Zheng Jiao
Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung Cancer. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Hao-Ran Dai, Hong-Li Guo, Ya-Hui Hu, Yun Liu, Ke-Yu Lu, Yuan-Yuan Zhang, Jie Wang, Xuan-Sheng Ding, Zheng Jiao, Rui Cheng, Feng Chen
Development and application of a population pharmacokinetic model repository for caffeine dose tailoring in preterm infants. Expert opinion on drug metabolism & toxicology (2024)
Wei-Jun Wang, Yue Li, Ya-Hui Hu, Jie Wang, Yuan-Yuan Zhang, Lin Fan, Hao-Ran Dai, Hong-Li Guo, Xuan-Sheng Ding, Feng Chen
Population pharmacokinetics of valproic acid in children with epilepsy: Implications for dose tailoring when switching from oral syrup to sustained-release tablets. CPT: pharmacometrics & systems pharmacology (2024)
Chen-Yu Wang, Hao-Ran Dai, Yu-Ping Tan, Di-Hong Yang, Xiao-Min Niu, Lu Han, Wen Wang, Ling-Ling Ma, Aleksi Julku, Zheng Jiao
Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung Cancer. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Hao-Ran Dai, Yang Yang, Chen-Yu Wang, Yue-Ting Chen, Yi-Fan Cui, Pei-Jing Li, Jia Chen, Chen Yang, Zheng Jiao
Trilaciclib dosage in Chinese patients with extensive-stage small cell lung cancer: a pooled pharmacometrics analysis. Acta pharmacologica Sinica (2024)
Hao-Ran Dai, Hong-Li Guo, Wei-Jun Wang, Xian Shen, Rui Cheng, Jing Xu, Ya-Hui Hu, Xuan-Sheng Ding, Feng Chen
From "wet" matrices to "dry" blood spot sampling strategy: a versatile LC-MS/MS assay for simultaneous monitoring caffeine and its three primary metabolites in preterm infants. Clinical chemistry and laboratory medicine (2023)
Yue Li, Dong Na, Yu-Xin Qin, Hao-Ran Dai, Ya-Hui Hu, Yue-Tao Zhao, Hong-Li Guo, Yuan-Yuan Zhang, Jing Chen, Xiao-Peng Lu, Feng Chen
Therapeutic drug monitoring of perampanel in children diagnosed with epilepsy: Focus on influencing factors on the plasma concentration-to-dose ratio. Epilepsia open 7 (4) (2022)
Jia-Yi Long, Ya-Hui Hu, Ying Xia, Fei-Fei Du, Hao-Ran Dai, Man Tian, Jing Xu, Rui Cheng, Xuan-Sheng Ding, Hong-Li Guo, Feng Chen
Therapeutic drug monitoring of caffeine and its primary metabolites in plasma using LC-ESI-MS/MS for apnea of prematurity treatment: Evaluation of ultrapure water as a surrogate matrix. Biomedical chromatography : BMC 36 (11) (2022)